Biodivide is a world leader in stem cell and regenerative medicines, tools, technologies and services. The Company combines extensive, applied, in-depth knowledge and expertise of the therapeutic and biotechnology applications of stem cells.
BioDivide was founded by Dr Erik Miljan to harness the biological power of stem cells. Dr Miljan has been directly involved with 7 human clinical trials involving stem cells ranging from early Phase I to late-stage Phase III trials. He has over 15 years’ experience in the development of stem cells for therapeutic and non-therapeutic (research and drug discovery) applications and is the named inventor on numerous patents. Dr Miljan has published over 30 peer-reviewed scientific journals, including Science magazine, which have been cited over 1,500 times.
“Not all stem cells are the same. Manufacturing a top quality stem cell product is understanding the biology and process that will give you different characteristics, whether it is consistency, purity or potency.”
Dr Erik Miljan, CEO, BioDivide founder and leading UK stem cell scientist
BioDivide bridges the gaps that represent barriers to the adoption of stem cells to regenerative medicine, technologies and services. We have the skills and expertise to design and engineer stem cell solutions across the entire workflow that uniquely focuses on the needs of the end-user.
BioDivide is a proud member of the United Kingdom’s Biotechnology Industry Association (BIA) and the Oxford Biotechnology Network (OBN)
